The Black Market for Investigational GLP-1 Drugs

The Black Market for Investigational GLP-1 Dr...

Up next

What's Next for Lp(a)?

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Lp(a)-Reducing Agent Pelacarsen Misses the Mark in Phase 3—Now What?" Related Content: Lp(a)-Reducing Agent Pelacarsen Misses the Mark in Phase 3—Now What? 

What Happens When Children Use AI for Support?

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss 1 in 5 Children Report Using AI for Emotional Support--Is It Good News or Bad? Related Content: More Than 1 in 5 Children Report Using AI for Emotional Support—Is It Good News or Bad? 

Recommended Episodes

Opioid Prescribing: Rising to the Challenge
JAMA Clinical Reviews

An opioid abuse epidemic now plagues US healthcare. It was caused, in part, by overzealous advocacy for controlling chronic pain resulting in overuse of narcotics. There are now 2 million Americans addicted to opioids. The approach for treating chronic pain must change. In this p ...  Show more

CBS Evening News, 02/26/25
CBS Evening News

The first U.S. measles death in nearly a decade has been reported at a Texas children’s hospital, as health officials race to contain the outbreak. The Supreme Court appeared poised to side with an Ohio woman in her bid to revive a lawsuit alleging "reverse discrimination" after ...  Show more

Opioids, COVID-19 And Racism: A Deadly Trifecta
Short Wave

Drug overdose deaths are on the rise all around the country, including in Chicago, Illinois. ProPublica Illinois reporter Duaa Eldeib explains how the coronavirus pandemic has exacerbated the opioid epidemic, and the challenges that public health officials are facing as they work ...  Show more